GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Cdx2
|
ENSMUSG00000029646.3 | caudal type homeobox 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Cdx2 | mm10_v2_chr5_-_147307264_147307281 | -0.35 | 3.8e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_131032061 | 8.97 |
ENSMUST00000084509.3
|
Dmbt1
|
deleted in malignant brain tumors 1 |
chr8_-_105933832 | 4.25 |
ENSMUST00000034368.6
|
Ctrl
|
chymotrypsin-like |
chr7_+_140763739 | 3.40 |
ENSMUST00000026552.7
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr11_-_99438143 | 2.84 |
ENSMUST00000017743.2
|
Krt20
|
keratin 20 |
chr9_-_65422773 | 2.67 |
ENSMUST00000065894.5
|
Slc51b
|
solute carrier family 51, beta subunit |
chr1_-_89933290 | 2.33 |
ENSMUST00000036954.7
|
Gbx2
|
gastrulation brain homeobox 2 |
chr5_+_146079254 | 2.31 |
ENSMUST00000035571.8
|
Cyp3a59
|
cytochrome P450, family 3, subfamily a, polypeptide 59 |
chr3_-_90695706 | 1.96 |
ENSMUST00000069960.5
ENSMUST00000117167.1 |
S100a9
|
S100 calcium binding protein A9 (calgranulin B) |
chrX_+_164090187 | 1.61 |
ENSMUST00000015545.3
|
Tmem27
|
transmembrane protein 27 |
chr14_+_80000292 | 1.33 |
ENSMUST00000088735.3
|
Olfm4
|
olfactomedin 4 |
chr17_+_80307396 | 1.13 |
ENSMUST00000068175.5
|
Arhgef33
|
Rho guanine nucleotide exchange factor (GEF) 33 |
chr4_-_64046925 | 1.11 |
ENSMUST00000107377.3
|
Tnc
|
tenascin C |
chr6_-_49214954 | 1.03 |
ENSMUST00000031838.7
|
Igf2bp3
|
insulin-like growth factor 2 mRNA binding protein 3 |
chr11_-_99244058 | 0.96 |
ENSMUST00000103132.3
ENSMUST00000038214.6 |
Krt222
|
keratin 222 |
chrX_+_96455359 | 0.85 |
ENSMUST00000033553.7
|
Heph
|
hephaestin |
chr1_-_144249134 | 0.82 |
ENSMUST00000172388.1
|
Rgs1
|
regulator of G-protein signaling 1 |
chr5_+_13399309 | 0.76 |
ENSMUST00000030714.7
ENSMUST00000141968.1 |
Sema3a
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
chr11_+_96323253 | 0.76 |
ENSMUST00000093944.3
|
Hoxb3
|
homeobox B3 |
chr18_+_65582239 | 0.70 |
ENSMUST00000182684.1
|
Zfp532
|
zinc finger protein 532 |
chrX_+_164140447 | 0.70 |
ENSMUST00000073973.4
|
Ace2
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
chr19_-_47692042 | 0.68 |
ENSMUST00000026045.7
ENSMUST00000086923.5 |
Col17a1
|
collagen, type XVII, alpha 1 |
chr3_+_57425314 | 0.66 |
ENSMUST00000029377.7
|
Tm4sf4
|
transmembrane 4 superfamily member 4 |
chr1_-_169747634 | 0.66 |
ENSMUST00000027991.5
ENSMUST00000111357.1 |
Rgs4
|
regulator of G-protein signaling 4 |
chrX_+_13632769 | 0.61 |
ENSMUST00000096492.3
|
Gpr34
|
G protein-coupled receptor 34 |
chr15_-_101491509 | 0.61 |
ENSMUST00000023718.7
|
5430421N21Rik
|
RIKEN cDNA 5430421N21 gene |
chr5_-_135744206 | 0.54 |
ENSMUST00000153399.1
ENSMUST00000043378.2 |
Tmem120a
|
transmembrane protein 120A |
chr18_+_65582390 | 0.53 |
ENSMUST00000169679.1
ENSMUST00000183326.1 |
Zfp532
|
zinc finger protein 532 |
chr6_-_13839916 | 0.50 |
ENSMUST00000060442.7
|
Gpr85
|
G protein-coupled receptor 85 |
chr1_-_163289214 | 0.48 |
ENSMUST00000183691.1
|
Prrx1
|
paired related homeobox 1 |
chr4_-_137118135 | 0.48 |
ENSMUST00000154285.1
|
Gm13001
|
predicted gene 13001 |
chr12_-_102878406 | 0.45 |
ENSMUST00000045652.6
|
Btbd7
|
BTB (POZ) domain containing 7 |
chr3_-_92485886 | 0.43 |
ENSMUST00000054599.7
|
Sprr1a
|
small proline-rich protein 1A |
chr3_+_126597415 | 0.43 |
ENSMUST00000066452.7
ENSMUST00000171289.1 ENSMUST00000106399.1 |
Camk2d
|
calcium/calmodulin-dependent protein kinase II, delta |
chr3_+_118433797 | 0.39 |
ENSMUST00000180593.1
ENSMUST00000181926.1 ENSMUST00000181060.1 ENSMUST00000181310.1 |
Gm26871
|
predicted gene, 26871 |
chr14_-_54686060 | 0.38 |
ENSMUST00000125265.1
|
Acin1
|
apoptotic chromatin condensation inducer 1 |
chr13_-_107890059 | 0.35 |
ENSMUST00000105097.2
|
Zswim6
|
zinc finger SWIM-type containing 6 |
chr12_+_85473883 | 0.35 |
ENSMUST00000021674.6
|
Fos
|
FBJ osteosarcoma oncogene |
chr1_-_186705980 | 0.33 |
ENSMUST00000045288.8
|
Tgfb2
|
transforming growth factor, beta 2 |
chr9_-_45936049 | 0.33 |
ENSMUST00000034590.2
|
Tagln
|
transgelin |
chr6_+_38918969 | 0.31 |
ENSMUST00000003017.6
|
Tbxas1
|
thromboxane A synthase 1, platelet |
chr5_+_90460889 | 0.31 |
ENSMUST00000031314.8
|
Alb
|
albumin |
chr3_+_95658771 | 0.31 |
ENSMUST00000178686.1
|
Mcl1
|
myeloid cell leukemia sequence 1 |
chr2_+_31759932 | 0.31 |
ENSMUST00000028190.6
|
Abl1
|
c-abl oncogene 1, non-receptor tyrosine kinase |
chr12_+_77238093 | 0.31 |
ENSMUST00000177595.1
ENSMUST00000171770.2 |
Fut8
|
fucosyltransferase 8 |
chr5_-_122697603 | 0.30 |
ENSMUST00000071235.4
|
Gm10064
|
predicted gene 10064 |
chr1_+_12692430 | 0.29 |
ENSMUST00000180062.1
ENSMUST00000177608.1 |
Sulf1
|
sulfatase 1 |
chr6_+_17491216 | 0.27 |
ENSMUST00000080469.5
|
Met
|
met proto-oncogene |
chr3_+_126597299 | 0.25 |
ENSMUST00000106400.2
ENSMUST00000106401.1 |
Camk2d
|
calcium/calmodulin-dependent protein kinase II, delta |
chr10_+_69787431 | 0.25 |
ENSMUST00000183240.1
|
Ank3
|
ankyrin 3, epithelial |
chr8_-_33843562 | 0.23 |
ENSMUST00000183062.1
|
Rbpms
|
RNA binding protein gene with multiple splicing |
chr18_+_37755718 | 0.23 |
ENSMUST00000061279.7
|
Pcdhga9
|
protocadherin gamma subfamily A, 9 |
chr3_-_10208569 | 0.23 |
ENSMUST00000029041.4
|
Fabp4
|
fatty acid binding protein 4, adipocyte |
chr18_+_65582281 | 0.23 |
ENSMUST00000183319.1
|
Zfp532
|
zinc finger protein 532 |
chr6_+_71199827 | 0.21 |
ENSMUST00000067492.7
|
Fabp1
|
fatty acid binding protein 1, liver |
chr2_+_31759993 | 0.18 |
ENSMUST00000124089.1
|
Abl1
|
c-abl oncogene 1, non-receptor tyrosine kinase |
chr8_+_54550324 | 0.18 |
ENSMUST00000033918.2
|
Asb5
|
ankyrin repeat and SOCs box-containing 5 |
chr17_-_31129602 | 0.18 |
ENSMUST00000024827.4
|
Tff3
|
trefoil factor 3, intestinal |
chr3_+_95658714 | 0.17 |
ENSMUST00000037947.8
|
Mcl1
|
myeloid cell leukemia sequence 1 |
chr6_-_71262232 | 0.16 |
ENSMUST00000129630.2
ENSMUST00000114186.2 ENSMUST00000074301.3 |
Smyd1
|
SET and MYND domain containing 1 |
chr15_+_3270767 | 0.13 |
ENSMUST00000082424.4
ENSMUST00000159158.1 ENSMUST00000159216.1 ENSMUST00000160311.1 |
Sepp1
|
selenoprotein P, plasma, 1 |
chrX_-_51205990 | 0.12 |
ENSMUST00000114876.2
|
Mbnl3
|
muscleblind-like 3 (Drosophila) |
chr5_+_121777929 | 0.08 |
ENSMUST00000160821.1
|
Atxn2
|
ataxin 2 |
chr3_-_14778452 | 0.07 |
ENSMUST00000094365.4
|
Car1
|
carbonic anhydrase 1 |
chr6_-_99044414 | 0.07 |
ENSMUST00000177507.1
ENSMUST00000123992.1 |
Foxp1
|
forkhead box P1 |
chr6_-_122340525 | 0.06 |
ENSMUST00000112600.2
|
Phc1
|
polyhomeotic-like 1 (Drosophila) |
chr19_-_34879452 | 0.06 |
ENSMUST00000036584.5
|
Pank1
|
pantothenate kinase 1 |
chr11_-_100105626 | 0.05 |
ENSMUST00000107416.2
|
Krt36
|
keratin 36 |
chr2_+_4300462 | 0.05 |
ENSMUST00000175669.1
|
Frmd4a
|
FERM domain containing 4A |
chr18_+_11839220 | 0.04 |
ENSMUST00000171109.1
ENSMUST00000046948.8 |
Cables1
|
CDK5 and Abl enzyme substrate 1 |
chr13_+_63282142 | 0.04 |
ENSMUST00000159152.1
|
2010111I01Rik
|
RIKEN cDNA 2010111I01 gene |
chr8_+_94386486 | 0.04 |
ENSMUST00000034220.7
|
Herpud1
|
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
chr10_+_52391606 | 0.02 |
ENSMUST00000067085.4
|
Nepn
|
nephrocan |
chrX_+_139684980 | 0.02 |
ENSMUST00000096313.3
|
Tbc1d8b
|
TBC1 domain family, member 8B |
chr15_+_23036449 | 0.02 |
ENSMUST00000164787.1
|
Cdh18
|
cadherin 18 |
chr8_+_15057646 | 0.01 |
ENSMUST00000033842.3
|
Myom2
|
myomesin 2 |
chr16_-_44016387 | 0.00 |
ENSMUST00000036174.3
|
Gramd1c
|
GRAM domain containing 1C |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.0 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.5 | 9.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 2.7 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 2.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.3 | 1.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 1.6 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 0.7 | GO:0015827 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.2 | 0.5 | GO:1990051 | negative regulation of phospholipase C activity(GO:1900275) activation of protein kinase C activity(GO:1990051) |
0.2 | 0.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 0.8 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
0.1 | 3.4 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.7 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 0.3 | GO:0035910 | endocardial cushion fusion(GO:0003274) apoptotic process involved in outflow tract morphogenesis(GO:0003275) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) positive regulation of catagen(GO:0051795) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
0.1 | 0.3 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
0.1 | 2.8 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.6 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.5 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.1 | 0.3 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.1 | 0.3 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.0 | 0.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.7 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 0.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.0 | 0.5 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.3 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.0 | 1.3 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.0 | 0.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.5 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.4 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 0.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.3 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.0 | 0.7 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.8 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 9.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 1.3 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.3 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 1.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 2.8 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 3.4 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.2 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.4 | GO:0001533 | cornified envelope(GO:0001533) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.3 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.3 | 2.3 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.2 | 2.0 | GO:0050786 | Toll-like receptor 4 binding(GO:0035662) RAGE receptor binding(GO:0050786) |
0.2 | 9.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 3.4 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 0.3 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.1 | 0.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.5 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.8 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.2 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.0 | 0.6 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 1.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 3.2 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 1.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 4.3 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 10.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 1.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.7 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.3 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |